SPONSOR
University of Kansas Medical Center
Total Trials
11
Recruiting
11
Phases
Phase 2, Phase 4
Conditions studied: Metabolism; Disorder, PostproceduralResting Metabolic RatePost Operative NutritionPulmonary HypertensionPulmonary Arterial HypertensionPulmonary Hypertension Due to Left Heart DiseasePulmonary Hypertension, PrimaryPulmonary Hypertension Due to Lung Diseases and HypoxiaPulmonary Hypertension, Primary, 4Pulmonary Hypertension, Primary, 2
University of Kansas Medical Center is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Metabolism; Disorder, Postprocedural, Resting Metabolic Rate, Post Operative Nutrition, Pulmonary Hypertension.
The trial portfolio spans Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Kansas Medical Center
How many clinical trials has University of Kansas Medical Center sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by University of Kansas Medical Center, of which 11 are actively recruiting participants. These trials cover conditions including Metabolism; Disorder, Postprocedural, Resting Metabolic Rate, Post Operative Nutrition. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Kansas Medical Center research focus on?
University of Kansas Medical Center clinical trials span Metabolism; Disorder, Postprocedural, Resting Metabolic Rate, Post Operative Nutrition, Pulmonary Hypertension, Pulmonary Arterial Hypertension, and additional conditions. The research pipeline includes Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Kansas Medical Center clinical trial?
To participate in a University of Kansas Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Kansas Medical Center trials with current recruitment status updated daily.
Clinical Trials by University of Kansas Medical Center
NCT06107959
Recruiting
Changes in Resting Metabolic Rate Following Orthopedic Surgery
Metabolism; Disorder, Postprocedural
NCT04808596
Recruiting
Pulmonary Hypertension Biorepository and Registry
Pulmonary Hypertension
NCT06645470
Recruiting
Muscle and Movement With Anti-Obesity Medications
Obesity and Overweight
NCT06434571 Phase 2
Recruiting
Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection
Multiple Sclerosis
NCT07422987
Recruiting
GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women
Body Composition
NCT03413982
Recruiting
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Bladder Cancer
NCT07087977
Recruiting
HoYAG vs TFL in miniPCNL With ClearPetra
Nephrolithiasis
NCT06379724 Phase 4
Recruiting
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
Burns
NCT06428006 Phase 2
Recruiting
Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis
Multiple Sclerosis
NCT07220135 Phase 2
Recruiting
Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
Breast Cancer
NCT06493370 Phase 2
Recruiting
Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer
Bladder Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology